Profile avatar
bioinformant.bsky.social
As the first and only market research firm to specialize in the stem cell industry, BioInformant.com is read by nearly 1 million readers per year. BioInformant has been cited by WSJ, Xconomy, and Vogue, as well as featured in Tony Robbin's book Life Force.
62 posts 156 followers 619 following
Prolific Poster
Posts 42 Comments 8

RoslinCT and Ayrmid Pharma Enter Into a Strategic Partnership to Manufacture FDA Approved Cell Therapy Omisirge® (omidubicel-onlv) - bioinformant.com/roslinct-and...

submitted 3 days ago • 0 comments

The Remarkable Rise of iPSC-derived MSC Therapeutics: iMSCs - bioinformant.com/ipsc-derived...

submitted 4 days ago • 0 comments

Cellino and Matricelf Collaborate to Scale iPSC-Derived Treatments for Spinal Cord Injury (SCI) - bioinformant.com/cellino-and-...

submitted 7 days ago • 0 comments

How CellPort Is Making Cell Culture Smarter – Interview with Patrick Dentinger, CEO of CellPort Software bioinformant.com/patrick-dent...

submitted 9 days ago • 0 comments

Garuda Therapeutics Closes $50 Million Series A-1 Financing to Advance Off-the-Shelf Blood Stem Cell Therapies - bioinformant.com/garuda-thera...

submitted 12 days ago • 0 comments

FDA Grants RMAT for ImmunityBio’s ANKTIVA® and CAR-NK in Reversal of Lymphopenia and Pancreatic Cancer Treatment - bioinformant.com/immunitybio-...

submitted 14 days ago • 0 comments

Exosome Research: Who Is Dominating in the Scientific Literature? - bioinformant.com/exosome-rese...

submitted 15 days ago • 0 comments

The Future of Allogeneic Cell Therapy is Off-the-Shelf and iPSC-Based – An Interview with Cellistic’s Founder and CTO, Stefan Braam, PhD - bioinformant.com/cellistic-st...

submitted 16 days ago • 0 comments

Venture Capital Funding Flowing into the iPSC Sector by Year - bioinformant.com/venture-capi... @aspenneuroscience.bsky.social @axolbio.bsky.social @synthego.bsky.social @evotec.bsky.social

submitted 17 days ago • 0 comments

A Complete Guide to Induced Pluripotent Stem Cell (iPSC) Core Facilities - bioinformant.com/the-what-whe...

submitted 17 days ago • 0 comments

Unlocking the Power of iPSCs: iPSC Product Categories and their Importance - bioinformant.com/ipsc-product...

submitted 20 days ago • 0 comments

Cellistic Launches Allo Chassis™: Ready-to-use, immune-cloaked #iPSC Cell Lines facilitating cost-effective cell therapy development - bioinformant.com/cellistic-la...

submitted 23 days ago • 0 comments

Gameto Announces FDA IND Clearance for Fertilo, the First iPSC-Based Therapy to Enter U.S. Phase 3 Clinical Trials - bioinformant.com/first-us-ips...

submitted 38 days ago • 0 comments

Ways to Curb the Sky-high Costs of CAR-T Cell Therapy - bioinformant.com/ways-to-curb... @miltenyibiotec.bsky.social @pennmedicine.bsky.social @capstantx.bsky.social

submitted 41 days ago • 0 comments

Cook MyoSite Announces Completion of Enrollment for the CELLEBRATE Study - bioinformant.com/cook-myosite... Cook MyoSite has completed enrollment for the Phase III trial evaluating iltamiocel, a #celltherapy, in reducing stress urinary incontinence episodes, with results expected mid-2026.

submitted 42 days ago • 0 comments

iPSC-Derived NK Cells and the Future of #Immunotherapy - bioinformant.com/ipsc-derived... iPSC-Derived NK Cells: The Australian biotech company, Cartherics Pty Ltd has a novel technology for inducing iNK cells from iPSCs.

submitted 42 days ago • 0 comments

REPROCELL’s Clinical-Grade iPSCs: Advancing Cell Therapy - bioinformant.com/reprocells-c... REPROCELL’s StemRNA(TM) Clinical iPSCs provide a benchmark for clinical grade iPSCs. They provide a foundation for various #celltherapy programs, ensuring safety, consistency, and regulatory compliance.

submitted 43 days ago • 0 comments

NecstGen Partners with Galapagos to Advance Decentralised CAR-T Cell Manufacturing in Europe - bioinformant.com/necstgen-gal...

submitted 44 days ago • 0 comments

VectorBuilder Powers FDA IND Approval of World’s First Umbilical Cord Blood-Derived Allogeneic CAR-T Product - bioinformant.com/vectorbuilde... @vectorbuilder.bsky.social

submitted 45 days ago • 0 comments

Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors - bioinformant.com/ginkgo-unive... @astellaspharma.bsky.social

submitted 45 days ago • 0 comments

7 Reasons to Take the CABP Exam In 2025 - bioinformant.com/cabp-exam/ @aabbupdates.bsky.social

submitted 45 days ago • 0 comments

Ncardia launches Ncyte® Heart in a Box - bioinformant.com/ncardia-hear... Ncardia, an iPSC technology company, announced the launch of Ncyte® Heart in a Box, a breakthrough 3D cardiac microtissue model designed to drive innovation in cardiovascular research and drug discovery.

submitted 48 days ago • 0 comments

I Peace establishes and offers low immunoreaction risk GMP iPS Cells - bioinformant.com/i-peace-low-... Three lines of GMP iPS Cells derived from type O female blood are now offered as off-the-shelf product.

submitted 49 days ago • 0 comments

Introducing AgentV, the Scalable Solution for 10X Exosome Yield - Webinar on Wed, Feb 12th at 11 ET www.roosterbio.com/products/age... Developed to overcome downstream process-related particle loss, AgentV™-DSP solves key DSP challenges and increases particle yields up to 10X over legacy solutions.

submitted 50 days ago • 0 comments

Ncardia launches Ncyte® Microglia - bioinformant.com/ncardia-laun... Ncardia, a global leader in human iPSC (hiPSC) technology, announced the launch of Ncyte® Microglia, a groundbreaking tool to advance research in #neurodegenerative diseases and central nervous system (CNS) disorders.

submitted 50 days ago • 0 comments

Innovative Functional Peptides Successfully Co-Developed as Alternatives to Growth Factors Used in the Manufacturing of Regenerative Medicine Products - bioinformant.com/innovative-f...

submitted 56 days ago • 0 comments

Innovative Functional Peptides Successfully Co-Developed as Alternatives to Growth Factors Used in the Manufacturing of Regenerative Medicine Products - bioinformant.com/innovative-f...

submitted 56 days ago • 0 comments

IntegriCell™ Cryopreservation Services from Cryoport Systems - www2.cryoport.com/l/946872/202... IntegriCell™ cryopreservation services from Cryoport Systems optimize leukapheresis-derived cell therapies by enhancing the safety, quality, and viability of manufacture-ready cryopreserved leukopaks.

submitted 58 days ago • 0 comments

Introducing AgentV: The Scalable Solution for 10X Exosome Yield RoosterBio developed AgentV™-DSP to address filtration problems. It provides advantages such as enabling use of smaller cutoff filters, greater filter loading capacity, and greater #exosome yield. us02web.zoom.us/webinar/regi...

submitted 58 days ago • 0 comments

Eterna Therapeutics Releases Positive Preclinical Results for ERNA-101, an Allogenic iMSC Therapeutic - bioinformant.com/eterna-imsc-...

submitted 59 days ago • 0 comments

Eterna Therapeutics Releases Positive Preclinical Results for ERNA-101, an Allogenic iMSC Therapeutic - bioinformant.com/eterna-imsc-...

submitted 59 days ago • 0 comments

IPS HEART’s Secures Orphan Drug Designation for iPSC-Derived Mesenchymal Progenitor Cell (MPC) Therapy, GIVI-MPC - bioinformant.com/ips-hearts-s...

submitted 64 days ago • 0 comments

Funding Flows Freely into Exosome Therapeutics in 2025 - bioinformant.com/exosome-fund...

submitted 66 days ago • 0 comments

CHU Toulouse receives CTA Approval to initiate ALLOFIST, a Phase 1/2 Trial based on Cell-Easy’s proprietary adipose-derived MSC in Patients suffering from Crohn Disease - bioinformant.com/chu-toulouse...

submitted 69 days ago • 0 comments

The most logical solutions are almost invisible to us because we haven't seen then, and so, we can't imagine them. Meaning, yes! Why shouldn't critical nutritional info appear on the FRONT of packing instead of the BACK?

submitted 71 days ago • 0 comments

Breaking: China’s NMPA Approves Country’s First MSC-Based Cell Therapy Ever, Ruibosheng! It is a human umbilical cord-derived mesenchymal stem cell therapy (amimestrocel injection). bioinformant.com/chinas-nmpa-...

submitted 71 days ago • 0 comments

"BrightPath Bio and Cellistic Announce Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell" bioinformant.com/brightpath-b... Companies to advance novel allogeneic CAR-T cell therapy platform, utilizing iPSC-derived NKT cells for trials.

submitted 73 days ago • 0 comments

Tolerance Bio Announces Scientific Advisory Board and $20.2M Seed Round to Advance Thymus-Based Therapies for Immune-Mediated Diseases - bioinformant.com/tolerance-bi...

submitted 73 days ago • 0 comments

MESOBLAST Achieves First Ever U.S. FDA Approval of an MSC Therapy (RYONCIL®) - bioinformant.com/mesoblasts-f...

submitted 73 days ago • 0 comments

Restoration of Whole-Person Health: Re-envisioning Global Access - bioinformant.com/restoration-... The HEALinc Global Summit will connects the dots between translational medicine and accelerating global access to cutting-edge advanced #longevity and #regenerative therapies.

submitted 76 days ago • 0 comments

I Peace manufactures 100 lines of GMP iPS Cells cumulatively - Provides proof of customer recognition of its quality and mass manufacturing capability. bioinformant.com/i-peace-manu... Many congrats to the I Peace team and CEO Koji Tanabe.

submitted 78 days ago • 0 comments

Restoration of Whole-Person Health: Re-envisioning Global Access - bioinformant.com/restoration-... The HEALinc Global Summit will connects the dots between translational medicine and accelerating global access to cutting-edge advanced #longevity and #regenerative therapies.

submitted 76 days ago • 0 comments